BERGISCH GLADBACH, April 20, 2017 – MACS® GMP T Cell TransAct™ is a ready-to-use reagent for efficient in vitro activation and expansion of human T cells. Also available in research grade.
Cell activation is a prerequisite for the successful genetic engineering of T cells. MACS GMP T Cell TransAct from Miltenyi Biotec – with its unique features – enables in vitro stimulation, activation, and expansion of human T cells from hematological cell populations (e.g. PBMCs). Polyclonal T cell expansion can be used in numerous applications including cellular therapy or whenever T cells are activated to improve gene modification.
Benefits of MACS GMP T Cell TransAct are:
Innovative format: A colloidal polymeric nanomatrix conjugated to humanized, recombinant CD3 and CD28 agonists.
Ease of use: Effective activation for a large range of cell densities.
Convenience: Excess reagent is simply washed off.
Safety: Biodegradable, ready to use and compatible with the automated, functionally-closed CliniMACS Prodigy® System.
For further information see miltenyibiotec.com/transact
Miltenyi Biotec Media ContactDr. Anja Kohmann
Publication free of charge – Specimen copy requested.
Seems like you are coming from USA!
Do you want to visit our website in your country?